| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &Immunovant CEO | President &COO | Chief Operating Officer
1 company
Venker Eric serves as a President &Immunovant CEO at ROIV. Across recent SEC filings that breaks down to 0 buys and 85 sells. Those positions are worth an estimated $58.5M at current prices.
Historically, Venker Eric's trades have earned a below-average insider score of 42/100 across 81 rated trades. Over a 12-month horizon, 16.1% of those trades were profitable, with an average 12-month return of -44.5%.
The biggest single holding is ROIV (~$58.5M) as President &Immunovant CEO. The recent filings there lean toward selling, a net 12,977,626 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 1,711,000 | $14.92 | $25,524,777.28 | -18.0% | +53.9% | - | |
| Aug 20, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 100,000 | $11.72 | $1,172,000.00 | -5.7% | +75.1% | - | |
| Jul 21, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 100,000 | $11.52 | $1,152,000.00 | -6.4% | +54.5% | +204.5% | |
| Jun 20, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.45 | $1,145,000.00 | -6.4% | +31.8% | +172.9% | |
| Jun 3, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 1,000,000 | $11.15 | $11,154,941.70 | -27.0% | +10.2% | +155.2% | |
| May 20, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $10.95 | $1,095,000.00 | -8.5% | +7.0% | +193.6% | |
| Apr 21, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $10.22 | $1,022,000.00 | -8.2% | +14.3% | - | |
| Mar 24, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 750,000 | $10.92 | $8,190,725.28 | -26.4% | +6.2% | +148.1% | |
| Feb 20, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $10.65 | $1,065,000.00 | -10.0% | +1.8% | +153.3% | |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 435,425 | $10.47 | $4,561,040.74 | -21.1% | +2.1% | +153.1% |